Clinical trial

Role of Parasympathetic Activity in Mild to Severe Asthma With Fixed Airway Obstruction (PARASMA Study)

NCT05550402

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Salbutamol Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Ipratropium Bromide Normalized identity: ipratropium bromideView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Salbutamol plus Ipratropium Bromide Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Role of Parasympathetic Activity in Mild to Severe Asthma With Fixed Airway Obstruction (PARASMA Study)

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2024-02-17

PhaseNA

Conditions

Asthmaverified · MONDO: asthma

Airway Obstructionunresolved

Airway Remodelingunresolved

Parasympathetic Nervous System Diseasesunresolved

Interventions

SalbutamolDRUG

Ipratropium BromideDRUG · verified · RxNorm: ipratropium bromide

Salbutamol plus Ipratropium BromideDRUG

PlaceboOTHER

Sponsors & collaborators

Hat Yai Medical Education Centerlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05550402 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.